BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36262502)

  • 1. 5-Fluorouracil-related Cardiotoxicity with Coronary Vasospasms.
    Faheem B; Kania B; Ashkar H; Bondili L; Maroules M
    J Community Hosp Intern Med Perspect; 2022; 12(5):71-74. PubMed ID: 36262502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is there a role for remote ischemic conditioning in preventing 5-fluorouracil-induced coronary vasospasm?
    Chong J; Ho AF; Yap J; Bulluck H; Hausenloy DJ
    Cond Med; 2019 Oct; 2(5):204-212. PubMed ID: 32133437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ST-Segment Elevation Myocardial Infarction Caused by 5-Fluorouracil-Related Cardiotoxicity.
    Balaji N; Dixit P; Adams AM; Faiz F; Ngwainmbi D; Henry G; Ghasemzadeh N
    Cureus; 2024 Jan; 16(1):e52864. PubMed ID: 38406077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Vasospasm and Microcirculatory Dysfunction in Fluoropyrimidine-Induced Ischemic Heart Disease.
    Fabin N; Bergami M; Cenko E; Bugiardini R; Manfrini O
    J Clin Med; 2022 Feb; 11(5):. PubMed ID: 35268333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capecitabine-induced coronary artery vasospasm in a patient who previously experienced a similar episode with fluorouracil therapy.
    Karakulak UN; Aladağ E; Maharjan N; Övünç K
    Turk Kardiyol Dern Ars; 2016 Jan; 44(1):71-4. PubMed ID: 26875134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Fluorouracil Rechallenge After Cardiotoxicity.
    Desai A; Mohammed T; Patel KN; Almnajam M; Kim AS
    Am J Case Rep; 2020 Aug; 21():e924446. PubMed ID: 32860674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bolus 5-fluorouracil (5-FU) In Combination With Oxaliplatin Is Safe and Well Tolerated in Patients Who Experienced Coronary Vasospasm With Infusional 5-FU or Capecitabine.
    Chakrabarti S; Sara J; Lobo R; Eiring R; Finnes H; Mitchell J; Hartgers M; Okano A; Halfdanarson T; Grothey A
    Clin Colorectal Cancer; 2019 Mar; 18(1):52-57. PubMed ID: 30396850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reintroduction of 5-Fluorouracil Post-cardiac Arrest Secondary to Chemotherapy-Induced Cardiotoxicity.
    Wu K; Bhattacharya P
    Cureus; 2023 Jan; 15(1):e34232. PubMed ID: 36852353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Case of 5-Fluorouracil-Induced Cardiac Arrest.
    Ray JC; Cho P; Dragon M; Graham CG
    J Emerg Med; 2016 Jan; 50(1):e1-6. PubMed ID: 26482827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S-1 as an alternative treatment after 5-fluorouracil-induced coronary vasospasm in a patient with small bowel adenocarcinoma: a case report.
    Mitome N; Machida N; Shichiri Y; Kuwashima H; Murai A; Maeda S
    Int Cancer Conf J; 2024 Jan; 13(1):40-44. PubMed ID: 38187174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoropyrimidine Cardiotoxicity: Time for a Contemporaneous Appraisal.
    Upshaw JN; O'Neill A; Carver JR; Dimond EP; Denlinger CS; Kircher SM; Wagner LI; Ky B; Brell JM
    Clin Colorectal Cancer; 2019 Mar; 18(1):44-51. PubMed ID: 30348619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-FU-induced cardiac toxicity--an underestimated problem in radiooncology?
    Steger F; Hautmann MG; Kölbl O
    Radiat Oncol; 2012 Dec; 7():212. PubMed ID: 23241239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiotoxicity following different doses and schedules of 5-fluorouracil administration for malignancy -- a survey of 427 patients.
    Tsavaris N; Kosmas C; Vadiaka M; Efremidis M; Zinelis A; Beldecos D; Sakelariou D; Koufos C; Stamatelos G
    Med Sci Monit; 2002 Jun; 8(6):PI51-7. PubMed ID: 12070449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-FU Cardiotoxicity: Vasospasm, Myocarditis, and Sudden Death.
    More LA; Lane S; Asnani A
    Curr Cardiol Rep; 2021 Feb; 23(3):17. PubMed ID: 33537861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoropyrimidine-Associated Cardiotoxicity.
    Kanduri J; More LA; Godishala A; Asnani A
    Cardiol Clin; 2019 Nov; 37(4):399-405. PubMed ID: 31587781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiotoxicity of 5-fluorouracil in combination with folinic acid in patients with gastrointestinal cancer.
    Schöber C; Papageorgiou E; Harstrick A; Bokemeyer C; Mügge A; Stahl M; Wilke H; Poliwoda H; Hiddemann W; Köhne-Wömpner CH
    Cancer; 1993 Oct; 72(7):2242-7. PubMed ID: 8374883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rare Presentation of Cardiotoxicity Related to 5-Fluorouracil.
    Charkviani M; Murvelashvili N; Barrera F; Sharma A; Eldin RS; Nabil NUN
    Case Rep Oncol Med; 2020; 2020():4151474. PubMed ID: 32774961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of preventing 5-fluorouracil cardiotoxicity by prophylactic treatment with verapamil.
    Eskilsson J; Albertsson M
    Acta Oncol; 1990; 29(8):1001-3. PubMed ID: 2278719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary Artery Vasospasm Induced by 5-fluorouracil: Proposed Mechanisms, Existing Management Options and Future Directions.
    Chong JH; Ghosh AK
    Interv Cardiol; 2019 May; 14(2):89-94. PubMed ID: 31178935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial fibrillation observed in a patient with esophageal cancer treated with fluorouracil.
    Moriyama S; Yokoyama T; Irie K; Ito M; Tsuchihashi K; Fukata M; Kusaba H; Maruyama T; Akashi K
    J Cardiol Cases; 2019 Nov; 20(5):183-186. PubMed ID: 31719941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.